Tissue Expression and Serum Concentrations of Amphiregulin and Epiregulin in Ovarian Endometrioma: A Pilot Case–Control Study

Background: Amphiregulin (AREG) and epiregulin (EREG) are epidermal growth factor family ligands involved in inflammation, cellular proliferation, and tissue remodeling. This pilot study compared tissue AREG and EREG mRNA expression and circulating protein concentrations between women with ovarian endometriomas and those with non-endometriotic benign ovarian cysts. Methods: This case–control study included 28 women undergoing ovarian cystectomy: 14 with histologically confirmed endometriomas and 14 with non-endometriotic benign ovarian cysts. Tissue mRNA expression was assessed using quantitative real-time PCR, and preoperative serum protein concentrations were measured by ELISA. Between-group comparisons used Mann–Whitney U tests with Benjamini–Hochberg adjustment. Exploratory analyses included within-endometrioma Spearman correlations and receiver operating characteristic analyses. Results: Median tissue AREG expression was 11.74 versus 0.83 (q < 0.001), and EREG expression was 1.95 versus 0.82 (q = 0.0105), with variable individual control values. CA125 was higher in endometrioma (50.30 versus 17.70; q = 0.0058). Serum EREG did not differ significantly (q = 0.2855). Serum AREG was lower in a sensitivity analysis assigning four right-censored observations to 1000 pg/mL (127.26 versus 296.02 pg/mL; q = 0.0149). Apparent tissue Area under the curve (AUC) were 0.992 for AREG and 0.827 for EREG. None of the six exploration within-endometrioma correlations reached unadjusted p < 0.05. Conclusions: Higher tissue AREG and EREG mRNA expressions were observed in ovarian endometrioma patients. The serum AREG finding depends on handling right-censored measurements. Small sample size, tissue heterogeneity, incomplete assay verification, and lack of independent validation limit biological and diagnostic interpretations.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2026-11-16
DOI
https://doi.org/10.3390/biomedicines14112638
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tissue Expression and Serum Concentrations of Amphiregulin and Epiregulin in Ovarian Endometrioma: A Pilot Case–Control Study

Selim Afşar, Gürhan Güney, Özgür Baykan, Mine İslimye Taşkın et al.
Biomedicines
Endometriosis Research and Treatment
article

Tissue Expression and Serum Concentrations of Amphiregulin and Epiregulin in Ovarian Endometrioma: A Pilot Case–Control Study

Selim Afşar, Gürhan Güney, Özgür Baykan, Mine İslimye Taşkın, Nazlı Şener, Figen Efe Çamili, Ayla Avcıkurt, Ceren Ovacik Karafilik
article en

Abstract

Background: Amphiregulin (AREG) and epiregulin (EREG) are epidermal growth factor family ligands involved in inflammation, cellular proliferation, and tissue remodeling. This pilot study compared tissue AREG and EREG mRNA expression and circulating protein concentrations between women with ovarian endometriomas and those with non-endometriotic benign ovarian cysts. Methods: This case–control study included 28 women undergoing ovarian cystectomy: 14 with histologically confirmed endometriomas and 14 with non-endometriotic benign ovarian cysts. Tissue mRNA expression was assessed using quantitative real-time PCR, and preoperative serum protein concentrations were measured by ELISA. Between-group comparisons used Mann–Whitney U tests with Benjamini–Hochberg adjustment. Exploratory analyses included within-endometrioma Spearman correlations and receiver operating characteristic analyses. Results: Median tissue AREG expression was 11.74 versus 0.83 (q < 0.001), and EREG expression was 1.95 versus 0.82 (q = 0.0105), with variable individual control values. CA125 was higher in endometrioma (50.30 versus 17.70; q = 0.0058). Serum EREG did not differ significantly (q = 0.2855). Serum AREG was lower in a sensitivity analysis assigning four right-censored observations to 1000 pg/mL (127.26 versus 296.02 pg/mL; q = 0.0149). Apparent tissue Area under the curve (AUC) were 0.992 for AREG and 0.827 for EREG. None of the six exploration within-endometrioma correlations reached unadjusted p < 0.05. Conclusions: Higher tissue AREG and EREG mRNA expressions were observed in ovarian endometrioma patients. The serum AREG finding depends on handling right-censored measurements. Small sample size, tissue heterogeneity, incomplete assay verification, and lack of independent validation limit biological and diagnostic interpretations.

BiomedicinesVol. 14(11)
Balıkesir University (TR), University of Turku (FI), Dokuz Eylül University (TR), Bandırma Onyedi Eylül University (TR)
Balikesir Üniversitesi
Good health and well-being
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon